AvalehtGEHC • NASDAQ
add
GE HealthCare Technologies Inc
68,42 $
Pärast sulgemist:(0,42%)+0,29
68,71 $
Suletud: 25. apr, 16:50:00 GMT −4 · USD · NASDAQ · Välistus
Viimane sulgemishind
67,05 $
Tänane vahemik
67,93 $ - 70,82 $
Aasta vahemik
57,65 $ - 94,80 $
Turuväärtus
31,33 mld USD
Keskmine maht
5,40 mln
P/E suhe
15,76
Dividendimäär
0,20%
Põhibörs
NASDAQ
Finantsandmed
Kasumiaruanne
Käive
Puhastulu
| (USD) | dets 2024info | Y/Y muutus |
|---|---|---|
Käive | 5,32 mld | 2,17% |
Põhitegevusega seonduv kulu | 1,39 mld | −4,07% |
Puhastulu | 721,00 mln | 78,91% |
Puhaskasumimarginaal | 13,56 | 75,19% |
Puhaskasum aktsia kohta | 1,45 | 22,88% |
EBITDA | 1,03 mld | 20,42% |
Tõhus maksumäär | 11,51% | — |
Bilansiaruanne
Kogu vara
Kõik kohustused
| (USD) | dets 2024info | Y/Y muutus |
|---|---|---|
Sularaha ja lühiajalised investeeringud | 2,87 mld | 15,20% |
Kogu vara | 33,09 mld | 1,96% |
Kõik kohustused | 24,44 mld | −2,81% |
Kogu omakapital | 8,65 mld | — |
Emiteeritud aktsiate arv | 457,30 mln | — |
Hinna ja väärtuse suhe P/B | 3,63 | — |
Varade tasuvus | 6,62% | — |
Kapitali tasuvus | 11,89% | — |
Rahavoog
Raha ja raha ekvivalentide muutus
| (USD) | dets 2024info | Y/Y muutus |
|---|---|---|
Puhastulu | 721,00 mln | 78,91% |
Põhitegevuse rahakäive | 913,00 mln | −13,05% |
Investeeringute raha | −240,00 mln | −172,73% |
Finantseerimise raha | −1,28 mld | −41,89% |
Raha ja raha ekvivalentide muutus | −679,00 mln | −889,53% |
Tasuta rahavoog | 1,05 mld | 12,27% |
Teave
GE Healthcare Technologies, Inc. is an American health technology company based in Chicago, Illinois. The company, which stylizes its own name as GE HealthCare, operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical Diagnostics, which manufactures contrast agents and radiopharmaceuticals.
The company's primary customers are hospitals and health networks. In 2023, the company received 42% of its revenue in the United States and 13% of its revenue from China, where the company faces increasing competition.
The company operates in more than 100 countries. GE Healthcare has major regional operations in Buc, France; Helsinki, Finland; Kraków, Poland; Budapest, Hungary; Yizhuang, China; Hino & Tokyo, Japan, and Bangalore, India. Its biggest R&D center is in Bangalore, India, built at a cost of $50 million. Wikipedia
Tegevjuht
Asutatud
1994
Veebisait
Töötajate arv
53 000
